All Articles

In a first for muscular dystrophy, Epicrispr's EPI-321 didn't just slow the disease—it increased lean muscle volume, signaling a new era for gene therapy.

Upexi joins the Russell Microcap Index, a milestone for any firm. But with a treasury heavy on volatile Solana, is this a new model for investors or a cautionary tale?

A landmark trial in Hawaiʻi brings together a tech innovator, a regional airline, and a legacy carrier to test the future of electric island hopping.

A rare disease drug's EU approval is revoked over 'misleading' data, impacting patients and signaling a new era of strict regulatory scrutiny for pharma giants.

By investing in startups like Magdent and Oral Genome, Dentalcorp is signaling a strategic shift, redefining the role of DSOs from managers to innovation engines.

Nasdaq-listed Jinxin Technology is betting its future on AI companions, moving from content to hardware to capture a slice of China's booming children's AI market.

How did a single Korean serum dethrone skincare giants on Amazon? Meditherapy's rise reveals a new blueprint for brand building in the digital age.

A new Redfin survey reveals overwhelming bipartisan support for housing affordability policies, creating a powerful public mandate for a landmark bill now stalled.

Fresh off a reverse merger, American Gold & Copper Inc. pivots to US soil, signing a deal for a promising copper-gold project in Nevada's famed Battle Mountain.

After a tumultuous delisting from Nasdaq, Luna Innovations finds a new home with TJC, trading public market woes for private equity's deep pockets.

First Responders Children's Foundation and T-Mobile are disrupting recognition by letting the public nominate heroes, a strategic shift in community engagement.

As Ontario's lowest-paid nurses demand fair wages from the Victorian Order of Nurses, their fight exposes a deep crisis threatening the province's home-care strategy.

A new partnership between Remote and isolved embeds global hiring into a major US HR platform, turning international expansion from a legal maze into a simple click.

As law firms face complex rules and fierce competition, generalist marketers are being dismissed. A look at why specialists like MileMark are the new counsel.

i-80 Gold issues $4.8M in shares to exit a restrictive sales contract, a calculated bet on higher gold prices and its ambitious Nevada growth strategy.

A new report reveals a startling shift: nearly half of Americans are cash-poor, and a growing number of them are middle-class, full-time workers.

At Europe's top energy expo, Fox ESS didn't just show new hardware; it revealed a calculated strategy of AI integration and market saturation. Is this the new blueprint?

The #HMC2026 conference revealed a Malaysian hospitality sector in deep recalibration, moving beyond old playbooks to forge resilience for its next growth era.

As Vivani Medical advances its long-acting semaglutide implant, a new board member with deep financial expertise signals a critical shift in strategy.

Incyte's Opzelura cream is one step closer to EU approval for atopic dermatitis, signaling a new era for patients and a major win for the company.